Weintraub, W. S., Bhatt, D. L., Zhang, Z., Dolman, S., Boden, W. E., Bress, A. P., King, J. B., Bellows, B. K., Tajeu, G. S., Derington, C. G., Johnson, J., Andrade, K., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Tardif, J.-C., Ballantyne, C. M., & Kolm, P. (2022). Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Network Open, 5(2), e2148172. https://doi.org/10.1001/jamanetworkopen.2021.48172